Rosenverse

Log in or create a free Rosenverse account to watch this video.

Log in Create free account

100s of community videos are available to free members. Conference talks are generally available to Gold members.

Digital Medicine Design
Thursday, September 26, 2019 • Enterprise Community
Share the love for this talk
Digital Medicine Design
Speakers: Daniel J. Rosenberg
Link:

Summary

Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both questions is a responding YES! In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical’s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24/7. The primary UX resides on the patients’ phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.

Key Insights

  • Digital medicine apps like BlueStar are prescription-only and undergo FDA clearance, making them legally a pharmaceutical class.

  • Only a tiny fraction (about 0.01%) of diabetes apps are FDA-cleared to ensure clinical effectiveness.

  • BlueStar outperforms metformin in lowering A1C by about 2 points through data science and gamification.

  • Bigfoot’s artificial pancreas integrates continuous glucose monitoring with an insulin pump controlled by smartphone, allowing personalized insulin dosing.

  • Medical UX design involves multi-actor systems including patients, caregivers, doctors, payers, pharmacies, and must consider HIPAA regulations.

  • The onboarding and provisioning processes in medical software are far more complex than in enterprise software due to prescriptions, insurance, and regulatory needs.

  • Safety is always the top design priority in digital medicine, followed by privacy and usability.

  • FDA agile process is highly regulated and closer to waterfall with strong documentation and traceability requirements, especially for higher-risk devices.

  • Contextual data like elevation, temperature, and activity levels can personalize insulin dosing algorithms in digital medicine products.

  • User retention issues in medical apps can sometimes mean success, as patients stop using the app after achieving stable health control.

Notable Quotes

"Digital medicine apps are legally considered a pharmaceutical, available by prescription only."

"About 200,000 digital health products exist, but only 1% of 1% have FDA clearance for accuracy."

"BlueStar lowered users' A1C by 2 points, outperforming the most common drug metformin which averages 1.5."

"If the phone dies, Bigfoot’s insulin pump continues working independently, but without new data input."

"You have to keep the injection sites moving because of scar tissue, adding to the body hacking complexity."

"Safety is your number one concern, privacy is your number two, and usability is number three."

"A lot of these companies have founders or investors who are themselves doctors or diabetic patients."

"Design history files must document every design decision for FDA audits—it's far more rigorous than typical usability tests."

"The FDA-approved agile process is more like a controlled waterfall with strict traceability, especially for Class 3 devices."

"If patients stop using the app because they’ve got their health under control, that’s like a dating app success — they got married, not that the app failed."

Ask the Rosenbot
Lona Moore
Scaling Design Beyond Designers
2021 • Design at Scale 2021
Gold
Billy Carlson
Tips to Utilize Wireframes to Tell an Effective Product Story
2023 • Enterprise UX 2023
Gold
Kristin Skinner
Theme 2: Introduction and Provocation
2024 • DesignOps Summit 2020
Gold
Kaaren Hanson
Stop Talking, Start Doing
2017 • Enterprise Experience 2017
Gold
Brendan Jarvis
It was the Best of Times. It was the Worst of Times.
2024 • DesignOps Summit 2024
Gold
Zariah Cameron
ReDesigning Wellbeing for Equitable Care in the Workplace
2024 • DesignOps Summit 2024
Gold
Bassel Deeb
Do More With Less: Equip and Lead Design Orgs Through Adversity
2023 • DesignOps Summit 2023
Gold
Sam Proulx
Understanding Screen Readers on Mobile: How And Why to Learn from Native Users
2023 • Advancing Research 2023
Gold
Ryan Matthew
Bridging Design and Code: AI-Powered Design System Integration
2025 • DesignOps Summit 2025
Gold
Sofia Quintero
The Product Philosophy Behind EnjoyHQ
2021 • Advancing Research 2021
Gold
Alla Weinberg
Cross-Functional Relationship Design
2022 • Design in Product 2022
Gold
PJ Buddhari
Meet Spectrum, Adobe’s Design System
2021 • Design at Scale 2021
Gold
Dr. Jamika D. Burge
How UX researchers can partner with (and not be replaced by) AI [Advancing Research Community Workshop Series]
2023 • Advancing Research Community
Sean McKay
Whole Product Thinking: Expanding beyond problem and solution space thinking
2024 • Rosenfeld Community
Sam Proulx
Accessibility: An Opportunity to Innovate
2022 • Design at Scale 2022
Gold
Alberto Ferreira
Making it Count: Developing a custom digital metric framework that works
2021 • QuantQual Interest Group

More Videos

Doug Powell

"Everything is a prototype."

Doug Powell

Closing Keynote: Design at Scale

November 8, 2018

Mila Kuznetsova

"Giving parents something meaningful to do during sessions helps keep them engaged and supportive."

Mila Kuznetsova Lucy Denton

How Lessons Learned from Our Youngest Users Can Help Us Evolve our Practices

March 9, 2022

Sarah Gallimore

"The mayor wanted to shrink the neighborly bonds that the city was known for by investing in a 2030 living Monument of collaboration and community."

Sarah Gallimore

Inspire Progress with Artifacts from the Future

November 18, 2022

Lada Gorlenko

"Simply asking stakeholders what success looks like for them in a project is a powerful way to start meaningful conversations."

Lada Gorlenko Sharbani Dhar Sébastien Malo Rob Mitzel Ivana Ng Michal Anne Rogondino

Theme 1: Discussion

January 8, 2024

Alnie Figueroa

"It is our job to lead and transform with empathy and heart because there’s fear in everyone."

Alnie Figueroa

The Future of Design Operations: Transforming Our Craft

September 10, 2025

Landon Barnes

"Research is not as easy as putting on a shoe and just doing it; it requires careful consideration and alignment with imperatives."

Landon Barnes

Are My Research Findings Actually Meaningful?

March 10, 2022

Emily Eagle

"When you encounter an obstacle, how do you respond? Maybe it’s an invitation to grow."

Emily Eagle

Can't Rewind: Radio and Retail

June 3, 2019

Malini Rao

"Re-platforming is transformative not just for the product but also for the people, teams, and organization."

Malini Rao

Lessons Learned from a 4-year Product Re-platforming Journey

June 9, 2021

Asia Hoe

"Collaborate and involve design early and often to better align on user goals and reduce friction."

Asia Hoe

Partnering with Product: A Journey from Junior to Senior Design

November 29, 2023